Physician
American Family Medicine LLC
American Family Medicine LLC was paid $9.47M by Medicaid between Jan 2018 and Dec 2024, across 147 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 70% of everything it billed.
33Billing provider infoAMERICAN FAMILY MEDICINE LLC
PHOENIX, AZ 85015
PHOENIX, AZ 85015
33aNPI1477908085assigned 05/02/2016
33bProvider typeGeneral Practice Physician
28Total paid$9.47M
24GClaims277,250
24DCodes billed147
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Practice Physician providers in Arizona
Rank by total paid#3 of 33
Median peer was paid$130K
This provider vs. median73×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 2,168 | $79K | |
| 2019 | 26,644 | $722K | |
| 2020 | 42,770 | $1.20M | |
| 2021 | 54,236 | $1.58M | |
| 2022 | 55,972 | $2.03M | |
| 2023 | 52,067 | $2.22M | |
| 2024incomplete | 43,393 | $1.65M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 70% | 98,550 | 76,575 | $6.65M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 6.8% | 12,010 | 10,450 | $645K |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | 3.2% | 3,234 | 3,182 | $302K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 2.1% | 15,351 | 14,569 | $196K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | 1.7% | 1,786 | 1,762 | $160K |
| 99385 | 1.7% | 1,593 | 1,566 | $157K | |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 1.4% | 3,291 | 3,194 | $133K |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | 1.3% | 1,993 | 1,638 | $118K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 1.2% | 2,426 | 2,210 | $110K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 1.1% | 1,218 | 1,211 | $106K |
| 36415 | Collection of venous blood by venipuncture | 1.0% | 32,925 | 31,066 | $98K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 1.0% | 1,116 | 1,104 | $97K |
135 more codes
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | <1% | 960 | $78K |
| 99386 | <1% | 629 | $69K | |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 461 | $59K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 607 | $58K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 4,149 | $53K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 2,166 | $49K |
| 93000 | <1% | 3,158 | $37K | |
| 81002 | <1% | 12,783 | $33K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 1,187 | $30K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 795 | $17K |
| 99397 | <1% | 517 | $17K | |
| 99205 | Prolong outpt/office vis | <1% | 98 | $12K |
| 82962 | <1% | 6,084 | $12K | |
| 99383 | <1% | 134 | $12K | |
| 99497 | <1% | 971 | $11K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 362 | $10K |
| 93229 | <1% | 12 | $10K | |
| 90686 | <1% | 1,185 | $10K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 650 | $9K |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | <1% | 31 | $9K |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 81 | $7K |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 80 | $6K |
| 99384 | <1% | 57 | $6K | |
| 90461 | <1% | 75 | $6K | |
| 99382 | <1% | 72 | $5K | |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | <1% | 655 | $5K |
| 99457 | <1% | 136 | $5K | |
| J2785 | Injection, regadenoson, 0.1 mg | <1% | 28 | $5K |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | <1% | 28 | $4K |
| 94760 | <1% | 2,097 | $3K | |
| 99454 | <1% | 91 | $3K | |
| 96160 | <1% | 1,604 | $3K | |
| 90682 | <1% | 97 | $3K | |
| 90688 | <1% | 217 | $3K | |
| 99381 | <1% | 27 | $2K | |
| 81025 | <1% | 344 | $2K | |
| 96127 | <1% | 495 | $2K | |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 56 | $2K |
| 99173 | <1% | 1,915 | $2K | |
| 87428 | <1% | 31 | $2K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 29 | $2K |
| 94664 | <1% | 93 | $2K | |
| 0011A | <1% | 46 | $1K | |
| 99188 | <1% | 107 | $1K | |
| 99458 | <1% | 44 | $1K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 744 | $1K |
| G0444 | Annual depression screening, 5 to 15 minutes | <1% | 443 | $1K |
| 90662 | <1% | 88 | $1K | |
| 90756 | <1% | 47 | $975.72 | |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | <1% | 31 | $686.88 |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | <1% | 251 | $670.06 |
| 0012A | <1% | 19 | $522.00 | |
| 93016 | <1% | 32 | $486.71 | |
| 99453 | <1% | 30 | $425.51 | |
| 99000 | <1% | 384 | $393.85 | |
| 93228 | <1% | 13 | $286.13 | |
| G0446 | Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes | <1% | 205 | $282.57 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 173 | $282.20 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 48 | $271.37 |
| 90651 | <1% | 141 | $250.00 | |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | <1% | 61 | $228.33 |
| 82270 | <1% | 42 | $171.97 | |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | <1% | 128 | $158.19 |
| J2920 | Injection, methylprednisolone sodium succinate, up to 40 mg | <1% | 40 | $147.18 |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 16 | $117.40 |
| J2360 | Injection, orphenadrine citrate, up to 60 mg | <1% | 16 | $85.73 |
| 90656 | <1% | 38 | $75.68 | |
| 94761 | <1% | 15 | $29.22 | |
| G0008 | Administration of influenza virus vaccine | <1% | 118 | $22.42 |
| 1159F | <1% | 8,633 | $19.68 | |
| 99072 | <1% | 314 | $16.80 | |
| 3008F | <1% | 6,125 | $7.98 | |
| 2000F | <1% | 976 | $7.98 | |
| 99499 | <1% | 1,407 | $2.84 | |
| G8427 | Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | <1% | 5,119 | $0.16 |
| G8417 | Bmi is documented above normal parameters and a follow-up plan is documented | 0% | 1,345 | $0.00 |
| G8753 | Most recent systolic blood pressure >= 140 mmhg | 0% | 184 | $0.00 |
| 3077F | 0% | 682 | $0.00 | |
| 3078F | 0% | 2,882 | $0.00 | |
| G9744 | Patient not eligible due to active diagnosis of hypertension | 0% | 1,883 | $0.00 |
| 4040F | 0% | 149 | $0.00 | |
| 4013F | 0% | 2,797 | $0.00 | |
| G8598 | Aspirin or another antiplatelet therapy used | 0% | 272 | $0.00 |
| G8752 | Most recent systolic blood pressure < 140 mmhg | 0% | 1,532 | $0.00 |
| 1160F | 0% | 639 | $0.00 | |
| 3050F | 0% | 96 | $0.00 | |
| G8783 | Normal blood pressure reading documented, follow-up not required | 0% | 213 | $0.00 |
| G8482 | Influenza immunization administered or previously received | 0% | 372 | $0.00 |
| 90633 | 0% | 157 | $0.00 | |
| 3288F | 0% | 211 | $0.00 | |
| 90670 | 0% | 322 | $0.00 | |
| 1100F | 0% | 40 | $0.00 | |
| 1090F | 0% | 44 | $0.00 | |
| 3095F | 0% | 164 | $0.00 | |
| 0518F | 0% | 17 | $0.00 | |
| G8431 | Screening for depression is documented as being positive and a follow-up plan is documented | 0% | 13 | $0.00 |
| 3725F | 0% | 15 | $0.00 | |
| 3074F | 0% | 2,017 | $0.00 | |
| G8754 | Most recent diastolic blood pressure < 90 mmhg | 0% | 2,527 | $0.00 |
| 3075F | 0% | 376 | $0.00 | |
| G8542 | Functional outcome assessment using a standardized tool is documented; no functional deficiencies identified, care plan not required | 0% | 294 | $0.00 |
| G8420 | Bmi is documented within normal parameters and no follow-up plan is required | 0% | 991 | $0.00 |
| 4086F | 0% | 778 | $0.00 | |
| 3017F | 0% | 200 | $0.00 | |
| 3048F | 0% | 592 | $0.00 | |
| 1125F | 0% | 48 | $0.00 | |
| 3079F | 0% | 718 | $0.00 | |
| 1036F | 0% | 1,080 | $0.00 | |
| 4010F | 0% | 2,612 | $0.00 | |
| 3080F | 0% | 90 | $0.00 | |
| 3044F | 0% | 934 | $0.00 | |
| 1126F | 0% | 143 | $0.00 | |
| 4008F | 0% | 682 | $0.00 | |
| G8734 | Elder maltreatment screen documented as negative, follow-up is not required | 0% | 226 | $0.00 |
| 4210F | 0% | 368 | $0.00 | |
| 0001F | 0% | 127 | $0.00 | |
| 3014F | 0% | 45 | $0.00 | |
| 90696 | 0% | 15 | $0.00 | |
| 90677 | 0% | 86 | $0.00 | |
| G9903 | Patient screened for tobacco use and identified as a tobacco non-user | 0% | 179 | $0.00 |
| 3049F | 0% | 133 | $0.00 | |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | 0% | 217 | $0.00 |
| 90620 | 0% | 29 | $0.00 | |
| 1170F | 0% | 277 | $0.00 | |
| 1220F | 0% | 15 | $0.00 | |
| 99070 | 0% | 280 | $0.00 | |
| 90619 | 0% | 12 | $0.00 | |
| 1111F | 0% | 87 | $0.00 | |
| 1101F | 0% | 170 | $0.00 | |
| 90680 | 0% | 128 | $0.00 | |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | 0% | 17 | $0.00 |
| 2001F | 0% | 18 | $0.00 | |
| 1123F | 0% | 26 | $0.00 | |
| 90697 | 0% | 27 | $0.00 | |
| 2010F | 0% | 23 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialLOPEZ, ALEJANDRO (MEDICAL DIRECTOR)
| Provider | Location | Paid |
|---|---|---|
| Alejandro Lopez JR, M.D.,P.A. | Alice, TX | $192.03 |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.